Loading...
Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients
BACKGROUND: Alopecia areata (AA) is a chronic autoimmune disorder characterized by patchy loss of hair from scalp, beard, eyebrows, or rarely even body hair. Rarely, the disease can be widespread and severe leading to loss of entire scalp and body hair causing apprehension and psychological stress i...
Saved in:
| Published in: | Int J Trichology |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Medknow Publications & Media Pvt Ltd
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6028993/ https://ncbi.nlm.nih.gov/pubmed/30034188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijt.ijt_21_18 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|